• Study on Cerebrolysin and Sodium Chloride for Patients with CADASIL

    Not recruiting

    2 1 1
    Investigated Diseases:
    Czechia
  • Study of MEN1611 and Eribulin for Advanced Metaplastic Breast Cancer in Patients with PIK3CA/PTEN Alterations

    Not recruiting

    2 1 1 1
    Spain
  • Study on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Portugal +1
  • Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    3 1 1 1
    Czechia Denmark France Germany Greece Italy +5
  • Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

    Not recruiting

    3 1 1 1
    Germany
  • Study on Testosterone Undecanoate for Muscle Strength and Mass in Men with Obesity and Low Testosterone Undergoing Bariatric Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Title: Study of gentamicin, vancomycin and cefazolin antibiotics to prevent infections in women having breast reconstruction surgery with implants

    Not recruiting

    3 1 1
    Denmark
  • Study of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy

    Not recruiting

    2 1 1 1
    Czechia

powered by